Sarepta Therapeutics
SRPT
SRPT
233 hedge funds and large institutions have $2.44B invested in Sarepta Therapeutics in 2017 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 104 increasing their positions, 34 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
+44
Holders Change %
+23.28%
% of All Funds
5.82%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.15%
New
68
Increased
104
Reduced
34
Closed
23
Calls
$312M
Puts
$256M
Net Calls
+$56.1M
Net Calls Change
-$14.7M
Top Buyers
| 1 |
FAM
Fred Alger Management
New York
|
+$57.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$46.8M |
| 3 |
BlackRock
New York
|
+$45.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$43.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.2M |
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$37.6M |
| 2 |
PA
Perceptive Advisors
New York
|
-$36.7M |
| 3 |
CCM
Cadian Capital Management
New York
|
-$20.9M |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$17.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.2M |
